ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,645Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1171

$2.05M Total Retail Price of All Prescriptions

Rank: 2 out of 1171

660 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 660 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 660 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 24,393 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
WARFARIN SODIUM 1,612 1,423 1 12
OMEPRAZOLE 881 712 2 5
FUROSEMIDE 879 754 3 6
SIMVASTATIN 867 737 4 1
LEVOTHYROXINE SODIUM 830 733 5 4
LISINOPRIL 717 586 6 3
AMLODIPINE BESYLATE 702 595 7 2
METOPROLOL TARTRATE 681 569 8 11
DONEPEZIL HCL 680 620 9 24
MIRTAZAPINE 612 544 10 50
NAMENDA 554 501 11 42
QUETIAPINE FUMARATE 550 400 12 54
GABAPENTIN 444 332 13 16
ATORVASTATIN CALCIUM 358 282 14 10
LEVEMIR FLEXPEN 357 352 10 15 145
METFORMIN HCL 335 278 16 7
KLOR-CON M20 331 295 17 41
NOVOLOG FLEXPEN 324 277 18 157
ESCITALOPRAM OXALATE 312 226 19 69
TRAZODONE HCL 311 246 20 37
CARVEDILOL 295 235 21 20
HYDRALAZINE HCL 278 219 22 60
LIDODERM 270 244 23 98
LEVETIRACETAM 268 180 24 84
POLYETHYLENE GLYCOL 3350 265 186 25 72
ALBUTEROL SULFATE 258 195 26 102
CLONIDINE 248 212 10 27 229
TAMSULOSIN HCL 246 199 28 28
CITALOPRAM HBR 241 199 29 22
FAMOTIDINE 220 162 30 75
CLONIDINE HCL 218 190 31 45
CYMBALTA 217 185 32 64
TRAMADOL HCL 211 194 33 18
ADVAIR DISKUS 204 168 34 51
LACTULOSE 204 185 34 108
ISOSORBIDE MONONITRATE ER 202 185 36 44
IPRATROPIUM-ALBUTEROL 190 144 37 130
CLOPIDOGREL 188 136 38 35
SERTRALINE HCL 176 131 39 23
OXYBUTYNIN CHLORIDE ER 174 135 40 135
CEPHALEXIN 173 144 41 104
SPIRIVA 172 140 42 57
CIPROFLOXACIN HCL 169 150 43 61
POTASSIUM CHLORIDE 169 134 43 19
ALLOPURINOL 168 157 45 31
RISPERIDONE 162 136 46 77
HYDROCHLOROTHIAZIDE 160 113 47 9
METOPROLOL SUCCINATE 156 144 48 17
LANTUS 156 104 48 46
DIGOXIN 144 144 50 68
SANTYL 143 129 51 173
ZETIA 136 127 52 63
DILTIAZEM 24HR CD 136 129 52 101
PHENYTOIN 136 78 52 256
ATENOLOL 136 114 52 15
GLUCAGEN 135 99 10 56 272
NYSTATIN 135 107 56 128
SEROQUEL 133 103 58 120
IPRATROPIUM BROMIDE 131 122 59 172
ALENDRONATE SODIUM 128 103 60 33
PREDNISONE 128 87 60 39
BUSPIRONE HCL 125 104 62 129
DIOVAN 125 113 62 32
SULFAMETHOXAZOLE-TRIMETHOPRIM 124 94 64 109
PANTOPRAZOLE SODIUM 121 97 65 29
FLUTICASONE PROPIONATE 121 106 65 30
KLOR-CON M10 120 106 67 125
ABILIFY 114 97 68 175
NOVOLOG 114 84 68 94
LOSARTAN POTASSIUM 114 108 68 14
LEVEMIR 109 105 71 167
HEPARIN SODIUM 106 71 72 204
EXELON 105 105 73 164
CARBAMAZEPINE 104 56 74 193
TRAVATAN Z 103 98 75 223
TRIAMCINOLONE ACETONIDE 102 60 76 133
LATANOPROST 99 93 77 188
NIFEDIPINE ER 97 86 78 114
PLAVIX 96 72 79 55
JANUVIA 96 96 79 66
LOVAZA 94 45 81 118
PROMETHAZINE HCL 93 64 R 82 87
GLIPIZIDE 91 68 83 47
NYSTOP 90 66 84 215
FINASTERIDE 89 85 85 88
BENZTROPINE MESYLATE 88 69 R 86 162
METOCLOPRAMIDE HCL 84 43 87 141
VENLAFAXINE HCL ER 84 78 87 113
PREVACID 81 78 89 317
LOPERAMIDE 81 69 89 262
HYDROCODONE-ACETAMINOPHEN 81 64 S3 89 8
SPIRONOLACTONE 78 54 92 53
HYDROCORTISONE 75 34 93 290
NEXIUM 75 71 93 25
SINGULAIR 73 66 95 78
AVELOX 72 69 96 209
CALCITRIOL 71 43 97 251
CRESTOR 70 68 98 27
PHENYTOIN SODIUM EXTENDED 69 56 99 137
BUMETANIDE 65 35 100 93
GLIMEPIRIDE 63 58 101 34
CHLORHEXIDINE GLUCONATE 62 49 102 285
DILTIAZEM HCL 61 61 103 247
BRIMONIDINE TARTRATE 59 57 104 257
CALCIUM ACETATE 59 39 104 296
VALPROIC ACID 58 32 106 245
DILTIAZEM ER 57 44 107 221
LEXAPRO 57 43 107 222
PROAIR HFA 56 37 109 49
FENOFIBRATE 55 32 110 81
PROPRANOLOL HCL 53 35 111 134
FLUCONAZOLE 53 51 111 195
DIVALPROEX SODIUM 53 43 111 106
AMIODARONE HCL 52 52 114 192
METOLAZONE 51 49 115 206
SODIUM CHLORIDE 51 51 115 265
AMOX TR-POTASSIUM CLAVULANATE 51 38 115 142
KETOCONAZOLE 51 38 115 217
CYCLOBENZAPRINE HCL 50 46 R 119 67
ZOLPIDEM TARTRATE 50 48 119 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.